• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依赖于 Lead 的三尖瓣功能障碍:经静脉 Lead 拔除术患者的机制和处理分析。

Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction.

机构信息

2nd Clinical Cardiology Department, Swietokrzyskie Cardiology Center, Kielce, Poland.

出版信息

Cardiol J. 2013;20(4):402-10. doi: 10.5603/CJ.2013.0099.

DOI:10.5603/CJ.2013.0099
PMID:23913459
Abstract

BACKGROUND

Lead-dependent tricuspid dysfunction (LDTD) is one of important complications in patients with cardiac implantable electronic devices. However, this phenomenon is probably underestimated because of an improper interpretation of its clinical symptoms. The aim of this study was to identify LDTD mechanisms and management in patients referred for transvenous lead extraction (TLE) due to lead-dependent complications.

METHODS

Data of 940 patients undergoing TLE in a single center from 2009 to 2011 were assessed and 24 patients with LDTD were identifi ed. The general indications for TLE, pacing system types and lead dwell time in both study groups were comparatively analyzed. The radiological and clinical effi cacy of TLE procedure was also assessed in both groups with precision estimation of clinical status patients with LDTD (before and after TLE). Additionally, mechanisms, concomitant lead-dependent complications and degree (severity) of LDTD before and after the procedure were evaluated. Telephone follow-up of LDTD patients was performed at the mean time 1.5 years after TLE/replacement procedure.

RESULTS

The main indications for TLE in both groups were similar (apart from isolated LDTD in 45.83% patients from group I). Patients with LDTD had more complex pacing systems with more leads (2.04 in the LDTD group vs. 1.69 in the control group; p = 0.04). There were more unnecessary loops of lead in LDTD patients than in the control group (41.7% vs. 5.24%; p = 0.001). There were no signifi cant differences in average time from implantation to extraction and the number of preceding procedures. Signifi cant tricuspid regurgitation (TR-grade III-IV) was found in 96% of LDTD patients, whereas stenosis with regurgitation in 4%. The 10% frequency of severe TR (not lead dependent) in the control group patients was observed. The main mechanism of LDTD was abnormal leafl et coaptation caused by: loop of the lead (42%), septal leafl et pulled toward the interventricular septum (37%) or too intensive lead impingement of the leafl ets (21%). LDTD patients were treated with TLE and reimplantation of the lead to the right ventricle (87.5%) or to the cardiac vein (4.2%), or surgery procedure with epicardial lead placement following ineffective TLE (8.3%). The radiological and clinical effi cacy of TLE procedure was very high and comparable between the groups I and II (91.7% vs. 94.2%; p = 0.6 and 100% vs. 98.4%; p = 0.46, respectively). Repeated echocardiography showed reduced severity of tricuspid valve dysfunction in 62.5% of LDTD patients. The follow- -up interview confi rmed clinical improvement in 75% of patients (further improvement after cardiosurgery in 2 patients was observed).

CONCLUSIONS

LDTD is a diagnostic and therapeutic challenge. The main reason for LDTD was abnormal leafl et coaptation caused by lead loop presence, or propping, or impingement the leafl ets by the lead. Probably, TLE with lead reimplantation is a safe and effective option in LDTD management. An alternative option is TLE with omitted tricuspid valve reimplantation. Cardiac surgery with epicardial lead placement should be reserved for patients with ineffective previous procedures.

摘要

背景

心脏植入式电子设备患者中,铅依赖性三尖瓣功能障碍(LDTD)是重要并发症之一。然而,由于对其临床症状的不当解读,这种现象可能被低估了。本研究旨在确定因导线相关并发症而接受经静脉导线拔除(TLE)的患者中 LDTD 的机制和处理方法。

方法

评估了 2009 年至 2011 年在一家中心接受 TLE 的 940 名患者的数据,并确定了 24 名 LDTD 患者。比较了两组患者 TLE 的一般适应证、起搏系统类型和导线留置时间。还评估了两组 TLE 手术的放射学和临床疗效,并对 LDTD 患者的临床状态进行了精确估计(TLE 前后)。此外,还评估了手术前后 LDTD 的机制、同时存在的导线依赖性并发症和严重程度(严重程度)。在 TLE/置换手术后 1.5 年,对 LDTD 患者进行了电话随访。

结果

两组患者的主要 TLE 适应证相似(第 I 组中有 45.83%的患者为孤立性 LDTD)。LDTD 患者的起搏系统更复杂,导线更多(LDTD 组 2.04 根,对照组 1.69 根;p=0.04)。LDTD 患者的导线中存在更多不必要的环路(41.7%比对照组的 5.24%;p=0.001)。从植入到拔除的平均时间和先前手术的数量在两组之间没有显著差异。96%的 LDTD 患者存在显著的三尖瓣反流(TR 分级 III-IV),而 4%的患者存在狭窄伴反流。在对照组患者中,观察到 10%的严重 TR(非导线依赖性)频率。LDTD 的主要机制是异常瓣叶对合,原因是:导线的环(42%)、隔瓣叶被拉向室间隔(37%)或导线对瓣叶的过度撞击(21%)。LDTD 患者接受 TLE 治疗,将导线重新植入右心室(87.5%)或心静脉(4.2%),或在 TLE 无效时进行心脏手术,在心外膜放置导线(8.3%)。TLE 手术的放射学和临床疗效非常高,两组之间无显著差异(第 I 组为 91.7%比 94.2%;p=0.6;第 II 组为 100%比 98.4%;p=0.46)。重复超声心动图显示 62.5%的 LDTD 患者三尖瓣功能障碍严重程度降低。随访访谈证实 75%的患者临床状况改善(2 例患者在心脏手术后进一步改善)。

结论

LDTD 是一个诊断和治疗上的挑战。LDTD 的主要原因是导线环的存在、导线的支撑或撞击导致瓣叶异常对合。可能,TLE 联合导线再植入是 LDTD 管理的一种安全有效的选择。另一种选择是 TLE 联合三尖瓣再植入的省略。对于先前治疗无效的患者,应保留心脏手术并在心外膜放置导线。

相似文献

1
Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction.依赖于 Lead 的三尖瓣功能障碍:经静脉 Lead 拔除术患者的机制和处理分析。
Cardiol J. 2013;20(4):402-10. doi: 10.5603/CJ.2013.0099.
2
Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.经皮起搏器或植入式心律转复除颤器导线移除术以改善症状性三尖瓣反流。
Europace. 2013 Mar;15(3):409-13. doi: 10.1093/europace/eus342. Epub 2012 Nov 28.
3
When should a mechanical tricuspid valve replacement be considered?何时应考虑行机械三尖瓣置换术?
J Thorac Cardiovasc Surg. 2014 Aug;148(2):603-8. doi: 10.1016/j.jtcvs.2013.09.043. Epub 2013 Nov 4.
4
The impact of transvenous lead extraction on tricuspid valve function.经静脉导线拔除对三尖瓣功能的影响。
Pacing Clin Electrophysiol. 2014 Jan;37(1):19-24. doi: 10.1111/pace.12236. Epub 2013 Aug 30.
5
Evaluation of tricuspid valve regurgitation following transvenous rotational mechanical lead extraction.评价经静脉旋转机械心内膜导线拔除术后三尖瓣反流情况。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae191.
6
Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.永久性起搏器或植入式心脏复律除颤器导线导致的严重症状性三尖瓣反流
J Am Coll Cardiol. 2005 May 17;45(10):1672-5. doi: 10.1016/j.jacc.2005.02.037.
7
3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.经胸超声心动图定位植入装置导线位置与三尖瓣反流相关机制。
JACC Cardiovasc Imaging. 2014 Apr;7(4):337-47. doi: 10.1016/j.jcmg.2013.11.007. Epub 2014 Mar 13.
8
Tricuspid valve repair for severe tricuspid regurgitation due to pacemaker leads.因起搏器导线导致严重三尖瓣反流的三尖瓣修复术。
Asian Cardiovasc Thorac Ann. 2016 Jul;24(6):541-5. doi: 10.1177/0218492316654775. Epub 2016 Jun 9.
9
Outcomes of tricuspid regurgitation after lead extraction.三尖瓣反流的经皮 Lead 取出术后结果。
J Cardiovasc Electrophysiol. 2024 May;35(5):929-938. doi: 10.1111/jce.16227. Epub 2024 Mar 7.
10
Permanent cardiac pacing and its influence on tricuspid valve function.永久性心脏起搏及其对三尖瓣功能的影响。
Folia Morphol (Warsz). 2001 Nov;60(4):249-57.

引用本文的文献

1
Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.经导管三尖瓣介入治疗三尖瓣反流:一篇叙述性综述。
Rev Cardiovasc Med. 2025 Aug 15;26(8):39915. doi: 10.31083/RCM39915. eCollection 2025 Aug.
2
Long-Term Complications Related to Cardiac Implantable Electronic Devices.与心脏植入式电子设备相关的长期并发症
J Clin Med. 2025 Mar 18;14(6):2058. doi: 10.3390/jcm14062058.
3
Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation-Proposed Algorithm and Selected Case Examples.
重度症状性三尖瓣反流患者心脏植入式电子设备的管理——拟议算法及精选病例示例
Catheter Cardiovasc Interv. 2025 May;105(6):1395-1406. doi: 10.1002/ccd.31444. Epub 2025 Feb 28.
4
Pacemaker lead extraction saved a severe lead-induced tricuspid regurgitation: a case report.起搏器导线拔除术挽救了严重的导线所致三尖瓣反流:一例报告
Eur Heart J Case Rep. 2024 Oct 18;8(11):ytae560. doi: 10.1093/ehjcr/ytae560. eCollection 2024 Nov.
5
Hybrid procedure: mini-invasive tricuspid valve plasty with transvenous lead extraction.杂交手术:经静脉导线拔除术联合微创三尖瓣成形术
Kardiochir Torakochirurgia Pol. 2024 Sep;21(3):184-187. doi: 10.5114/kitp.2024.143491. Epub 2024 Sep 23.
6
First Case of the Treatment of Massive Tricuspid Regurgitation With the CroíValve DUO Coaptation Valve in a Patient With a Right Ventricular Pacemaker Lead.首例使用CroíValve DUO贴合瓣膜治疗右心室起搏器导线患者的严重三尖瓣反流。
Struct Heart. 2024 Jun 25;8(5):100329. doi: 10.1016/j.shj.2024.100329. eCollection 2024 Sep.
7
New Therapeutic Advances in the Management of Tricuspid Valve Regurgitation.三尖瓣反流治疗的新进展
J Clin Med. 2024 Aug 6;13(16):4599. doi: 10.3390/jcm13164599.
8
Success and safety of deep sedation as a primary anaesthetic approach for transvenous lead extraction: a retrospective analysis.深镇静作为经静脉导线拔除术主要麻醉方法的效果和安全性:回顾性分析。
Sci Rep. 2023 Dec 27;13(1):22964. doi: 10.1038/s41598-023-50372-1.
9
Stepwise Approach for Transvenous Lead Extraction in a Large Single Centre Cohort.大型单中心队列中经静脉导线拔除的逐步方法
J Clin Med. 2023 Dec 11;12(24):7613. doi: 10.3390/jcm12247613.
10
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a 'heart team' approach.经皮三尖瓣置换或修复术患者的导管理:一种“心脏团队”方法。
Europace. 2023 Nov 2;25(11). doi: 10.1093/europace/euad300.